Tune into episode 50 of the Benchtop Bios Podcast Series featuring Dr. Graeme Smith, Chief Scientific Officer of Artios Pharma, as he discusses the PARP inhibitor drug, Lynparza® and two new DDR-targeting, clinical stage assets developed at Artios.
Listen here: https://open.spotify.com/episode/0qAAovrmvre8KTY2EMI9Yl